The field of immuno-oncology has emerged as a breakthrough in cancer treatment by harnessing the patient’s immune system to detect and kill tumor cells. Poseida exists to create novel cell and gene therapy products to treat patients with high unmet medical need, initially focusing on CAR-T product candidates for oncology indications.